Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > naked shorts or HFT have lots of paper

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Jul 03, 2018 3:24pm

122 Views

Post# 28263735

RE:RE:RE:naked shorts or HFT have lots of paper

I also took all my shares last night and set a limit sell order here at a higher than above average value that I feel can be met ....so they no longer have my shares to borrow
i suggest you all do the same

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale